Page last updated: 2024-09-04

canertinib and bms345541

canertinib has been researched along with bms345541 in 1 studies

Compound Research Comparison

Studies
(canertinib)
Trials
(canertinib)
Recent Studies (post-2010)
(canertinib)
Studies
(bms345541)
Trials
(bms345541)
Recent Studies (post-2010) (bms345541)
12496598063

Protein Interaction Comparison

ProteinTaxonomycanertinib (IC50)bms345541 (IC50)
Inhibitor of nuclear factor kappa-B kinase subunit betaHomo sapiens (human)1
Inhibitor of nuclear factor kappa-B kinase subunit alphaHomo sapiens (human)4.54
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1

Other Studies

1 other study(ies) available for canertinib and bms345541

ArticleYear
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011